Journal Article

Financial Impact of a Home Intravenous Antibiotic Program on a Medicare Managed Care Program

Joseph R. Dalovisio, Jan Juneau, Katherine Baumgarten and Joan Kateiva

in Clinical Infectious Diseases

Published on behalf of Infectious Diseases Society of America

Volume 30, issue 4, pages 639-642
Published in print April 2000 | ISSN: 1058-4838
Published online April 2000 | e-ISSN: 1537-6591 | DOI: http://dx.doi.org/10.1086/313755
Financial Impact of a Home Intravenous Antibiotic Program on a Medicare Managed Care Program

More Like This

Show all results sharing these subjects:

  • Infectious Diseases
  • Immunology
  • Public Health and Epidemiology
  • Microbiology

GO

Show Summary Details

Preview

This study quantitates cost savings achieved by a home intravenous antibiotic (HIVA) program in a Medicare managed health care program. In 1998, 66 treatment courses of HIVA therapy were administered for a total of 1542 patient-days of therapy. The calculated cost of HIVA therapy included the actual costs of drugs, supplies, nursing and therapists' salaries, and laboratory studies. Savings were calculated based on the average daily direct variable cost (DDVC) for hospital acute unit or skilled nursing facility (SNF) care associated with the patient's discharge diagnosis-related-group. The number of days on HIVA therapy was assumed to equal the number of days in the hospital acute unit or hospital-based SNF. The average cost per day of HIVA therapy was $122, whereas average DDVC of hospital acute unit care was $798, and the average DDVC of SNF care was $541. In 1 year, the HIVA program saved our health care system $646,000–$834,000, which demonstrates that HIVA programs are powerful tools to reduce costs in Medicare managed health care programs.

Journal Article.  2293 words.  Illustrated.

Subjects: Infectious Diseases ; Immunology ; Public Health and Epidemiology ; Microbiology

Full text: subscription required

How to subscribe Recommend to my Librarian

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.